Biotech Pre-Seed Investors & VC Firms
915 firms in this list, with a median first check of $250K. 237 of them lead rounds. Generated from verified public data and updated continuously.
Mountain Group Capital
NashvillePre-Seed–Seed
13 people
Page One Ventures
Silicon ValleyPre-Seed–Series A
4 people
Wireframe Ventures
San FranciscoPre-Seed–Seed$500K – $2M
3 people
Divergent Capital
New YorkPre-Seed–Seed$250K – $1M
7 people
QUBIS
BelfastPre-Seed–Seed$12.7K – $127K
11 people
Toronto Innovation Acceleration Partners
TorontoPre-Seed–Seed
11 people
XGEN Venture
MilanPre-Seed–Series A
21 people
Borealis Ventures
HanoverPre-Seed–Series A$1M – $2.5M
13 people
Bioqube Ventures
BrusselsPre-Seed–Series B$108K – $6.5M
17 people
ISV
West Palm BeachPre-Seed–Series A
17 people
Sprout
Palmerston NorthPre-Seed–Seed
20 people
Cistern Capital
New YorkPre-Seed–Seed
19 people
Natural Products Canada
CharlottetownPre-Seed–Seed$350K
22 people
Prime Partners
TokyoPre-Seed–Growth
4 people
BSV Ventures
VilniusPre-Seed–Seed$5K – $430K
9 people
Cloud Health Euroventures
Pre-Seed–Series A$100K – $1M
21 people
Foresite Labs
San FranciscoPre-Seed
24 people
Innoventures Iowa
IowaPre-Seed–Seed
12 people
TechVision Fund
AachenPre-Seed–Series A$500K – $2M
17 people
Axial VC
San FranciscoPre-Seed–Seed$100K – $5M
2 people
Creative Ventures
San Francisco Bay AreaPre-Seed–Series A$1M
9 people
Founderful
ZurichPre-Seed–Series A$108K – $1.6M
13 people
Alkemi Growth Capital
New DelhiPre-Seed–Growth
15 people
AQC Capital
MontréalPre-Seed–Seed
20 people
Related lists
Pre-Seed Investors & VC Firms (5569)Pre-Seed Investors & VC Firms in North America (3004)Pre-Seed Investors & VC Firms in United States (2671)Biotech Investors & VC Firms (2475)AI & Machine Learning Pre-Seed Investors & VC Firms (2102)Biotech Seed Investors & VC Firms (2020)Fintech Pre-Seed Investors & VC Firms (1711)SaaS Pre-Seed Investors & VC Firms (1652)Biotech Series A Investors & VC Firms (1626)Pre-Seed Investors & VC Firms in Europe (1598)
Data sourced from public filings and firms' own websites — see our methodology.





























































































